G1 Therapeutics, Inc. (GTHX) Social Stream
G1 THERAPEUTICS INC (GTHX) Price Targets From Analysts
Use the tables below to see what analysts covering G1 THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-12 | 7 | $71 | $19 | $43.333 | $3.24 | 1237.44% |
| 2022-02-23 | 7 | $71 | $19 | $40.833 | $3.24 | 1160.28% |
| 2022-02-24 | 7 | $71 | $20 | $38.6 | $3.24 | 1091.36% |
| 2022-04-27 | 6 | $71 | $20 | $34.8 | $3.24 | 974.07% |
| 2022-05-05 | 6 | $71 | $17 | $33 | $3.24 | 918.52% |
| 2022-07-29 | 6 | $67 | $17 | $32.2 | $3.24 | 893.83% |
| 2022-08-04 | 7 | $67 | $17 | $32.5 | $3.24 | 903.09% |
| 2022-09-16 | 7 | $67 | $14 | $32 | $3.24 | 887.65% |
| 2022-11-03 | 7 | $57 | $14 | $31 | $3.24 | 856.79% |
| 2022-11-11 | 7 | $57 | $7 | $29.833 | $3.24 | 820.77% |
| 2022-11-23 | 7 | $34 | $7 | $26 | $3.24 | 702.47% |
| 2023-01-03 | 7 | $34 | $7 | $25.833 | $3.24 | 697.31% |
| 2023-01-05 | 8 | $35 | $7 | $27.142 | $3.24 | 737.72% |
| 2023-01-30 | 7 | $35 | $7 | $26 | $3.24 | 702.47% |
| 2023-03-24 | 7 | $31 | $5 | $16.666 | $3.24 | 414.38% |
| 2023-04-19 | 7 | $24 | $5 | $14.5 | $3.24 | 347.53% |
| 2023-08-03 | 7 | $19 | $5 | $11.833 | $3.24 | 265.22% |
| 2023-08-17 | 7 | $19 | $5 | $11.166 | $3.24 | 244.63% |
| 2023-10-30 | 7 | $19 | $5 | $11.4 | $3.24 | 251.85% |
| 2023-11-03 | 7 | $19 | $5 | $11 | $3.24 | 239.51% |
The Trend in the Analyst Price Target
Over the past 43 weeks, GTHX's average price target has gone down $14.08.
Over the past 40 weeks, GTHX's average upside potential has been 463.36%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-02 | 7 | 31 | 5 | 16.666 | 3.64 | 357.86% |
| 2023-03-24 | 7 | 31 | 5 | 16.666 | 2.57 | 548.48% |
| 2023-05-04 | 7 | 19 | 5 | 11.833 | 3.14 | 276.85% |
| 2023-11-03 | 6 | 14 | 5 | 9.333 | 1.67 | 458.86% |
| 2023-11-03 | 5 | 14 | 5 | 9.333 | 1.67 | 458.86% |
GTHX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 3 | 1 | 0 | 1 | 1 | 5 |
The Trend in the Broker Recommendations
Over the past 19 months, GTHX's average broker recommendation rating worsened by 0.03.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, G1 THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 2360.06% of them.
- In the context of all US stocks, G1 THERAPEUTICS INC's variance in analysts' estimates is lower than -2235.58% of them.
- GTHX has a higher number of analysts covering the stock than 1965.02% of stocks in the small market cap category.
- GTHX has a greater average analyst price target than 1537.16% of stocks in the small market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to G1 THERAPEUTICS INC are MRSN, AEZS, and MRUS.
View All Top Stocks by Price Target
Is GTHX a Buy, Hold or Sell? See the POWR Ratings now!